The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Updated results of European Organization for Research and Treatment of Cancer (EORTC) phase 2 trial 1202 cabazitaxel in patients with metastatic or inoperable locally advanced dedifferentiated liposarcoma.
 
Roberta Sanfilippo
Travel, Accommodations, Expenses - PharmaMar
 
Richard L Hayward
No Relationships to Disclose
 
Jammbe Musoro
No Relationships to Disclose
 
Charlotte Benson
No Relationships to Disclose
 
Michael Gordon Leahy
No Relationships to Disclose
 
Antonella Brunello
Consulting or Advisory Role - GlaxoSmithKline
Speakers' Bureau - Lilly
Travel, Accommodations, Expenses - Ipsen; PharmaMar
 
Jean-Yves Blay
Leadership - Innate Pharma
Honoraria - AstraZeneca; Bayer; BMS; Deciphera; Ignyta; MSD; PharmaMar; Roche
Consulting or Advisory Role - Bayer; Blueprint Medicines; Deciphera; Deciphera; Deciphera; Deciphera; Pharmamar; Roche
Research Funding - AstraZeneca (Inst); Bayer (Inst); BMS (Inst); DEciphera (Inst); GlaxoSmithKline (Inst); MSD (Inst); Novartis (Inst); OSE Pharma (Inst); Pharmamar (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Roche
 
Neeltje Steeghs
Consulting or Advisory Role - AIMM Therapeutics (Inst); Boehringer Ingelheim (Inst); Ellipses Pharma (Inst)
Research Funding - AB Science (Inst); Abbvie (Inst); Actuate Therapeutics (Inst); Amgen (Inst); Array BioPharma (Inst); AstraZeneca/MedImmune (Inst); Bayer (Inst); Blueprint Medicines (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Cantargia AB (Inst); Cytovation (Inst); Deciphera (Inst); Genentech (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Incyte (Inst); InteRNA (Inst); Lilly (Inst); Merck Sharp & Dohme (Inst); Merus (Inst); Novartis (Inst); Pfizer (Inst); Pierre Fabre (Inst); Roche (Inst); Sanofi (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst)
 
Ingrid Desar
No Relationships to Disclose
 
Nasim Ali
No Relationships to Disclose
 
Alice Hervieu
No Relationships to Disclose
 
Khin Thway
No Relationships to Disclose
 
Sandrine Marreaud
No Relationships to Disclose
 
Saskia Litiere
No Relationships to Disclose
 
Bernd Kasper
No Relationships to Disclose